European Archives - Page 58 of 1166 - European Medical Journal

Pulmonary Embolism in Youth Carries Notable Mortality Risk

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.

Preoperative MRI May Not Improve Outcomes in HER2-Positive Breast Cancer

Understand how preoperative MRI does not boost survival in HER2-positive, HR-negative breast cancer

First Trial Shows Psilocybin is Safe and Effective in Parkinson’s Disease

Discover how psilocybin therapy could transform Parkinson’s care – read more about this promising pilot trial and future directions.

New Blood Test Shows Promise in Predicting Melanoma Recurrence Risk

A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.

No Clear Benefit of Vitamins in Preventing Type 1 Diabetes, Study Shows

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.

Rethinking Sleep Apnoea: It’s Not Just Obesity

Discover a recent study that debunks the myth that obesity is always to blame in patients with obstructive sleep apnoea.

Bariatric Surgery Improves Survival in Patients with Cirrhosis

Notably, the study found that bariatric surgery was cost-effective based on the incremental cost-effectiveness ratio.

GLP-1 Receptor Agonists Tied to Increased Fracture Risks in Elderly: WCO 2025

New data suggest that elderly individuals with type 2 diabetes who initiate GLP-1 receptor agonist therapy may face a slightly higher risk of bone fractures compared to those using other common diabetes

Does Smoking Help with Ulcerative Colitis?

Smoking may reduce the risk of developing ulcerative colitis and alleviate disease severity in existing cases.

Low-Dose Aspirin Found Safe for Pregnant Patients With Inflammatory Bowel Disease

Pregnant individuals with IBD prescribed low-dose aspirin were no more likely to experience flares than those not on aspirin, according to a new study, easing concerns about its use in this high-risk population.